Publications by authors named "Raquel Rivera"

Claim this Profile
P
Preferred use of contraceptive methods and reasons for non-use: a cross-sectional survey of a sample of Black, Indigenous, and people of colour in the United States.
Alexandra Wollum, Katherine Key, Carmela Zuniga, Charon Asetoyer, Maricela Cervantes, Raquel Z Rivera

Sex Reprod Health Matters· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa.
Mercè Grau-Pérez, Cristina Ciudad, Alejandro Molina-Leyva, Antonio Martorell, Eva Vilarrasa, Raquel Rivera

Dermatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic and Clinical Characteristics, Patterns of Treatment, Quality of Life, and Resource Consumption Associated with the Management of Patients with Moderate to Severe Psoriasis in Clinical Practice in Spain: The SUMMER Project.
Jaime Notario, Jorge Magdaleno-Tapial, Raquel Rivera, Josep Riera-Monroig, Conrad Pujol

Dermatol Ther (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Benefits of Licensed Midwifery and Community Birth Among BIPOC Birthing People in New Mexico.
Raquel Z Rivera, Micaela Lara Cadena, Jess F Gutfreund, Esperanza Dodge

Birth· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting.
Esteban Daudén, Elena Escario, Luisa Martos-Cabrera, Susana Armesto, Enrique Herrera-Acosta, Raquel Rivera

Int J Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients.
Nerea Manzanares, Eva Vilarrasa, Anna López, Maria Luisa Alonso, Manel Velasco, Raquel Rivera

J Eur Acad Dermatol Venereol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: An online cross-sectional survey.
Katherine Key, Alexandra Wollum, Charon Asetoyer, Maricela Cervantes, Alyssa Lindsey, Raquel Z Rivera

Contraception· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab to guselkumab transitions: A series of 54 patients emulating the navigate trial in real life.
Sonsoles Berenguer-Ruiz, Raquel Rivera, Pedro Herranz, Pablo De la Cueva, Mercedes Hospital

Dermatol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.
Pablo Chicharro, Mar Llamas-Velasco, Susana Armesto, Enrique Herrera-Acosta, David Vidal, Raquel Rivera

Dermatol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry.
Mónica Munera-Campos, Jaime Vilar-Alejo, Raquel Rivera, Jose-Manuel Carrascosa, Esteban Daudén

J Dermatolog Treat· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study.
Raquel Rivera, E Vilarrasa, M Ribera, E Roe, T Kueder-Pajares

J Dermatolog Treat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Elena Del Alcázar, Anna López-Ferrer, Álvaro Martínez-Doménech, Ricardo Ruiz-Villaverde, Mª Del Mar Llamas-Velasco, Raquel Rivera

Dermatol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain.
Esteban Daudén, Glauber Pacelli Gomes de Lima, Susana Armesto, Enrique Herrera-Acosta, David Vidal, Raquel Rivera

Dermatol Ther (Heidelb)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach.
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel

World J Gastroenterol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
Ofelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, José Manuel Carrascosa, Esteban Daudén

J Am Acad Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Satveer K Mahil, Nick Dand, Kayleigh J Mason, Zenas Z N Yiu, Teresa Tsakok, Raquel Rivera

J Allergy Clin Immunol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
Carlos Pelayo Hernández-Fernández, Gregorio Carretero, Raquel Rivera, Carlos Ferrándiz, Esteban Daudén

Acta Derm Venereol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project.
Rubén Queiro, Pablo Coto, Beatriz Joven, Raquel Rivera, Teresa Navío Marco

Reumatol Clin (Engl Ed)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study.
Raquel Rivera, Manuel Velasco, David Vidal, J Manuel Carrascosa, Esteban Daudén

Dermatol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry.
Esteban Daudén, Gregorio Carretero, Raquel Rivera, Carlos Ferrándiz, Mar Llamas-Velasco

J Am Acad Dermatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg.
Mar Llamas-Velasco, Ofelia Baniandrés, Raquel Rivera, Ana Reymundo Jimenez, Mercedes Hospital

Dermatol Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of urinary tract infections in patients with psoriasis on systemic medications in Biobadaderm Registry: A prospective cohort study.
Antonio Sahuquillo-Torralba, Gregorio Carretero, Raquel Rivera, Carlos Ferrándiz, Esteban Daudén-Tello

J Am Acad Dermatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study.
Andrea Montes-Torres, Gloria Aparicio, Raquel Rivera, Eva Vilarrasa, María Marcellán

J Dermatolog Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain.
Jordi Gratacós, Jesús Luelmo, Jesús Rodríguez, Jaume Notario, Teresa Navío Marco, Raquel Rivera

Rheumatol Int· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change over time in the rates of adverse events in patients receiving systemic therapy for psoriasis: A cohort study.
Miguel Angel Descalzo, Gregorio Carretero, Carlos Ferrándiz, Raquel Rivera, Esteban Daudén

J Am Acad Dermatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis